ArticleFrontiers in oncology2021

Development and Validation of an Immune-Related Signature for the Prediction of Recurrence Risk of Patients With Laryngeal Cancer.

Hang Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.